Home/Filings/4/0001127602-24-023455
4//SEC Filing

Spaid John L 4

Accession 0001127602-24-023455

CIK 0000877860other

Filed

Sep 3, 8:00 PM ET

Accepted

Sep 4, 7:42 PM ET

Size

33.4 KB

Accession

0001127602-24-023455

Insider Transaction Report

Form 4
Period: 2024-09-03
Spaid John L
CFO/EVP Finance
Transactions
  • Exercise/Conversion

    Common Stock

    2024-09-03$53.41/sh+18,333$979,16644,252.637 total
  • Exercise/Conversion

    Common Stock

    2024-09-03$53.41/sh+1$5362,586.637 total
  • Exercise/Conversion

    Common Stock

    2024-09-03$54.73/sh+8,500$465,20579,586.637 total
  • Exercise/Conversion

    Stock Option (Right to Buy) 2023

    2024-09-038,5000 total
    Exercise: $54.73From: 2023-02-24Exp: 2028-02-24Common Stock (8,500 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy) 2023

    2024-09-038,5000 total
    Exercise: $54.73From: 2024-02-24Exp: 2028-02-24Common Stock (8,500 underlying)
  • Exercise/Conversion

    Common Stock

    2024-09-03$53.41/sh+18,333$979,16662,585.637 total
  • Exercise/Conversion

    Common Stock

    2024-09-03$54.73/sh+8,500$465,20571,086.637 total
  • Exercise/Conversion

    Common Stock

    2024-09-03$57.76/sh+8,500$490,96088,086.637 total
  • Exercise/Conversion

    Stock Option (Right to buy) 2022

    2024-09-0318,3330 total
    Exercise: $53.41From: 2022-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
  • Tax Payment

    Common Stock

    2024-09-03$81.43/sh49,637$4,041,94138,449.637 total
  • Exercise/Conversion

    Stock Option (Right to buy) 2022

    2024-09-0318,3330 total
    Exercise: $53.41From: 2023-02-25Exp: 2027-02-25Common Stock (18,333 underlying)
  • Exercise/Conversion

    Stock Option (Right to buy) 2022

    2024-09-0310 total
    Exercise: $53.41From: 2024-02-25Exp: 2027-02-25Common Stock (1 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy) 2024

    2024-09-038,5000 total
    Exercise: $57.76From: 2024-02-23Exp: 2029-02-23Common Stock (8,500 underlying)
Holdings
  • Stock Option (Right to Buy) 2024

    Exercise: $57.76From: 2025-02-23Exp: 2029-02-23Common Stock (8,500 underlying)
    8,500
  • Stock Option (Right to Buy) 2024

    Exercise: $57.76From: 2026-02-23Exp: 2029-02-23Common Stock (8,500 underlying)
    8,500
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2020-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2022-02-21Exp: 2025-02-21Common Stock (18,334 underlying)
    18,334
  • Stock Options (Right to Buy) 2-21-2020

    Exercise: $90.79From: 2021-02-21Exp: 2025-02-21Common Stock (18,333 underlying)
    18,333
  • Stock Option (Right to Buy) 2023

    Exercise: $54.73From: 2025-02-24Exp: 2028-02-24Common Stock (8,500 underlying)
    8,500
Footnotes (1)
  • [F1]Acquired due to the net exercise of stock options granted 2/25/22, 2/24/23 and 2/23/24 with shares withheld by the Company to cover the exercise price and taxes. This transaction was completed subsequent to the execution of a Lock-Up Agreement and shares received are subject to the provisions of that agreement.

Issuer

NATIONAL HEALTH INVESTORS INC

CIK 0000877860

Entity typeother

Related Parties

1
  • filerCIK 0001667637

Filing Metadata

Form type
4
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 7:42 PM ET
Size
33.4 KB